These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 26092924)

  • 1. Effectiveness of pneumococcal conjugate vaccine against presumed bacterial pneumonia hospitalisation in HIV-uninfected South African children: a case-control study.
    Madhi SA; Groome MJ; Zar HJ; Kapongo CN; Mulligan C; Nzenze S; Moore DP; Zell ER; Whitney CG; Verani JR
    Thorax; 2015 Dec; 70(12):1149-55. PubMed ID: 26092924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology of invasive bacterial infections in pneumococcal conjugate vaccine-vaccinated and -unvaccinated children under 5 years of age in Soweto, South Africa: a cohort study from a high-HIV burden setting.
    Johnstone SL; Moore DP; Klugman KP; Madhi SA; Groome MJ
    Paediatr Int Child Health; 2020 Feb; 40(1):50-57. PubMed ID: 31156062
    [No Abstract]   [Full Text] [Related]  

  • 3. Risk Factors for Presumed Bacterial Pneumonia Among HIV-uninfected Children Hospitalized in Soweto, South Africa.
    Verani JR; Groome MJ; Zar HJ; Zell ER; Kapongo CN; Nzenze SA; Mulligan C; Moore DP; Whitney CG; Madhi SA
    Pediatr Infect Dis J; 2016 Nov; 35(11):1169-1174. PubMed ID: 27276181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The potential impact of pneumococcal conjugate vaccine in Africa: Considerations and early lessons learned from the South African experience.
    Madhi SA; Nunes MC
    Hum Vaccin Immunother; 2016; 12(2):314-25. PubMed ID: 26317537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Introduction of pneumococcal conjugate vaccine into the public immunization program in South Africa: translating research into policy.
    Madhi SA; Cohen C; von Gottberg A
    Vaccine; 2012 Sep; 30 Suppl 3():C21-7. PubMed ID: 22939016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pneumococcal conjugate vaccine--a health priority.
    Zar HJ; Madhi SA
    S Afr Med J; 2008 Jun; 98(6):463-7. PubMed ID: 18683380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of conjugate pneumococcal vaccination in Singapore: comparing estimates for 7-valent, 10-valent, and 13-valent vaccines.
    Tyo KR; Rosen MM; Zeng W; Yap M; Pwee KH; Ang LW; Shepard DS
    Vaccine; 2011 Sep; 29(38):6686-94. PubMed ID: 21745516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study.
    Whitney CG; Pilishvili T; Farley MM; Schaffner W; Craig AS; Lynfield R; Nyquist AC; Gershman KA; Vazquez M; Bennett NM; Reingold A; Thomas A; Glode MP; Zell ER; Jorgensen JH; Beall B; Schuchat A
    Lancet; 2006 Oct; 368(9546):1495-502. PubMed ID: 17071283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for invasive pneumococcal disease among children less than 5 years of age in a high HIV prevalence setting, South Africa, 2010 to 2012.
    von Mollendorf C; Cohen C; de Gouveia L; Naidoo N; Meiring S; Quan V; Lindani S; Moore DP; Reubenson G; Moshe M; Eley B; Hallbauer UM; Finlayson H; Madhi SA; Conklin L; Zell ER; Klugman KP; Whitney CG; von Gottberg A;
    Pediatr Infect Dis J; 2015 Jan; 34(1):27-34. PubMed ID: 24992122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of 7-valent pneumococcal conjugate vaccine in the prevention of invasive pneumococcal disease in children aged 7-59 months. A matched case-control study.
    Domínguez A; Ciruela P; García-García JJ; Moraga F; de Sevilla MF; Selva L; Coll F; Muñoz-Almagro C; Planes AM; Codina G; Jordán I; Esteva C; Hernández S; Soldevila N; Cardeñosa N; Batalla J; Salleras L
    Vaccine; 2011 Nov; 29(48):9020-5. PubMed ID: 21939724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Five-year cohort study on the burden of hospitalisation for acute diarrhoeal disease in African HIV-infected and HIV-uninfected children: potential benefits of rotavirus vaccine.
    Groome MJ; Madhi SA
    Vaccine; 2012 Apr; 30 Suppl 1():A173-8. PubMed ID: 22520128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of monovalent human rotavirus vaccine against admission to hospital for acute rotavirus diarrhoea in South African children: a case-control study.
    Groome MJ; Page N; Cortese MM; Moyes J; Zar HJ; Kapongo CN; Mulligan C; Diedericks R; Cohen C; Fleming JA; Seheri M; Mphahlele J; Walaza S; Kahn K; Chhagan M; Steele AD; Parashar UD; Zell ER; Madhi SA
    Lancet Infect Dis; 2014 Nov; 14(11):1096-1104. PubMed ID: 25303843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of the 10-valent pneumococcal conjugate vaccine against radiographic pneumonia among children in rural Bangladesh: A case-control study.
    McCollum ED; Ahmed S; Roy AD; Chowdhury NH; Schuh HB; Rizvi SJR; Hanif AAM; Khan AM; Mahmud A; Pervaiz F; Harrison M; Reller ME; Simmons N; Quaiyum A; Begum N; Santosham M; Checkley W; Moulton LH; Baqui AH;
    Vaccine; 2020 Sep; 38(42):6508-6516. PubMed ID: 32873404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in pneumococcal vaccination of children.
    Russell FM; Mulholland EK
    Ann Trop Paediatr; 2004 Dec; 24(4):283-94. PubMed ID: 15720885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology of invasive pneumococcal disease in the pre-conjugate vaccine era: South Africa, 2003-2008.
    von Gottberg A; Cohen C; de Gouveia L; Meiring S; Quan V; Whitelaw A; Crowther-Gibson P; Madhi SA; Whitney CG; Klugman KP
    Vaccine; 2013 Aug; 31(38):4200-8. PubMed ID: 23684826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of the 10-Valent Pneumococcal Conjugate Vaccine (PCV-10) in Children in Chile: A Nested Case-Control Study Using Nationwide Pneumonia Morbidity and Mortality Surveillance Data.
    Diaz J; Terrazas S; Bierrenbach AL; Toscano CM; Alencar GP; Alvarez A; Valenzuela MT; Andrus J; del Aguila R; Hormazábal JC; Araya P; Pidal P; Matus CR; de Oliveira LH
    PLoS One; 2016; 11(4):e0153141. PubMed ID: 27058873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acquisition of Streptococcus pneumoniae in South African children vaccinated with 7-valent pneumococcal conjugate vaccine at 6, 14 and 40 weeks of age.
    Nunes MC; Jones SA; Groome MJ; Kuwanda L; Van Niekerk N; von Gottberg A; de Gouveia L; Adrian PV; Madhi SA
    Vaccine; 2015 Jan; 33(5):628-34. PubMed ID: 25541213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of different pneumococcal conjugate vaccine schedules against pneumonia, hospitalisation, and mortality: re-analysis of a randomised trial in the Gambia.
    Mackenzie GA; Bottomley C; van Hoek AJ; Jeffries D; Ota M; Zaman SM; Greenwood B; Cutts F
    Vaccine; 2014 May; 32(21):2493-500. PubMed ID: 24631086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in hospitalizations for pneumonia after universal vaccination with pneumococcal conjugate vaccines 7/13 valent and haemophilus influenzae type b conjugate vaccine in a Pediatric Referral Hospital in Uruguay.
    Pírez MC; Algorta G; Chamorro F; Romero C; Varela A; Cedres A; Giachetto G; Montano A
    Pediatr Infect Dis J; 2014 Jul; 33(7):753-9. PubMed ID: 24492286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of the ten-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) against invasive pneumococcal disease: a cluster randomised trial.
    Palmu AA; Jokinen J; Borys D; Nieminen H; Ruokokoski E; Siira L; Puumalainen T; Lommel P; Hezareh M; Moreira M; Schuerman L; Kilpi TM
    Lancet; 2013 Jan; 381(9862):214-22. PubMed ID: 23158882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.